Mold research and data

That absence of standards is what makes mold marketing possible. When there is no threshold, a spore count can be presented as alarming without any benchmark to compare it against. When you are shown a lab report, the correct question is: what number would have been acceptable, and who set it?

On health, the mainstream position is narrower than the marketing. Mold exposure can trigger allergic and respiratory symptoms in some people, and people with asthma, allergies, or compromised immune systems can be more sensitive. The dramatic claims — that indoor mold causes neurological damage or that a specific illness can be traced to a specific home — are not established. The CDC's review of the once-publicized link between Stachybotrys and infant pulmonary hemorrhage found the original analysis flawed and the association unproven.

The practical takeaway from the research is unglamorous and consistent across agencies: control moisture, remove growth, do not fixate on species, and take health questions to a physician rather than to a contractor.

How to choose

Ask what the benchmark is

There are no federal mold limits, so any 'unsafe level' claim on a lab report has no official standard behind it.

Distinguish association from causation

Mold can trigger symptoms in sensitive people. That is not the same as a diagnosis for a specific person in a specific house.

Prefer agency guidance to vendor literature

EPA and CDC materials are free, public, and not selling remediation.

Use research to calibrate spend

Money is better spent on moisture control and removal than on species identification.